CANDIDA-ALBICANS GENOTYPING IN STUDIES WITH PATIENTS WITH AIDS DEVELOPING RESISTANCE TO FLUCONAZOLE

被引:113
|
作者
BARTDELABESSE, E [1 ]
BOIRON, P [1 ]
CARLOTTI, A [1 ]
DUPONT, B [1 ]
机构
[1] UNIV CLAUDE BERNARD LYON 1, MYCOL FONDAMENTALE & APPL BIOTECHNOL IND LAB, F-69373 LYON, FRANCE
关键词
D O I
10.1128/JCM.31.11.2933-2937.1993
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We characterized Candida albicans strains responsible for recurrent oropharyngeal candidosis (OPC) in four patients with AIDS who developed clinical and mycological resistance to fluconazole (FCZ). Karyotype and restriction fragment length polymorphism analyses were performed on the clonal populations to differentiate relapse from reinfection, and the results were assessed with those of serotype and FCZ MICs. Despite the polymorphism in chromosomal bands larger than 2.2 Mbp related to an intraclonal variation, karyotype analysis showed a single strain type attributable to each patient. On the other hand, EcoRI and HinfI restriction fragments revealed a polymorphism for one patient between the first sample and the subsequent ones, relevant to the acquisition of a new strain causing the following episodes of OPC. This result coincided with switching of the serotype and with the acquisition of a resistance to FCZ. For the other three patients, the similarity of the DNA electrophoretic patterns and the serotype of the samples suggested that recurrence can be due to the initial strain that generates FCZ resistance. Although useful for epidemiological studies, molecular typing methods seem to be inadequate to detect the acquisition of FCZ resistance.
引用
收藏
页码:2933 / 2937
页数:5
相关论文
共 50 条
  • [31] PULMONARY TISSUE RESISTANCE TO CANDIDA-ALBICANS
    NUGENT, KM
    ONOFRIO, JM
    CLINICAL RESEARCH, 1982, 30 (04): : A739 - A739
  • [32] SYNERGY OF MACROPHAGES (MP) WITH FLUCONAZOLE (FCZ) FOR KILLING CANDIDA-ALBICANS
    GARCHA, UK
    BRUMMER, E
    STEVENS, DA
    FASEB JOURNAL, 1995, 9 (04): : A1040 - A1040
  • [33] FAILURE OF FLUCONAZOLE THERAPY FOR STERNAL OSTEOMYELITIS DUE TO CANDIDA-ALBICANS
    DAN, M
    PRIEL, I
    CLINICAL INFECTIOUS DISEASES, 1994, 18 (01) : 126 - 127
  • [34] USE OF FLUCONAZOLE IN THE TREATMENT OF CANDIDA-ALBICANS HYDROCEPHALUS SHUNT INFECTION
    CRUCIANI, M
    DIPERRI, G
    MOLESINI, M
    VENTO, S
    CONCIA, E
    BASSETTI, D
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (10) : 957 - 957
  • [35] SUCCESSFUL TREATMENT OF A CANDIDA-ALBICANS SEPSIS WITH A COMBINATION OF FLUCYTOSINE AND FLUCONAZOLE
    SCHEVEN, M
    JUNEMANN, K
    SCHRAMM, H
    HUHN, W
    MYCOSES, 1992, 35 (11-12) : 315 - 316
  • [36] CANDIDA-ALBICANS FROM AIDS PATIENTS - SUSCEPTIBILITY INVITRO TO ANTIFUNGAL AGENTS
    ALVES, SH
    CURY, AE
    GOMPERTZ, OF
    SILVA, TDJ
    REVISTA DE MICROBIOLOGIA, 1992, 23 (02): : 133 - 135
  • [37] ESOPHAGEAL INVOLVEMENT BY CANDIDA-ALBICANS IN PATIENTS WITH AIDS-RELATED COMPLEX
    CLOTET, B
    GRIFOL, M
    PARRA, O
    MEDICINA CLINICA, 1986, 87 (04): : 169 - 170
  • [38] Proteomic analysis of fluconazole resistance in Candida albicans
    Wang, Zhiyuan
    Zhang, Gehua
    Zhang, Xiaoli
    Wu, Si
    Yin, Xingfeng
    Zhang, Hong
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 6 (16): : 1226 - 1230
  • [39] Candida albicans Genotyping and Relationship of Virulence Factors with Fluconazole Tolerance in Infected Pediatric Patients
    Mashaly, Ghada El-Saeed
    Zeid, Mayada Sabry
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 2035 - 2043
  • [40] STUDIES ON GROWTH AND INHIBITION OF CANDIDA-ALBICANS
    NORDBRINGHERTZ, B
    PHYSIOLOGIA PLANTARUM, 1955, 8 (03) : 691 - 717